NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Spirit Aviation Holdings, Inc.("Spirit" or the "Company") (NYSE:FLYY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Spirit and certain of its officers and/or […]
NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ:SRPT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against CTO Realty Growth, Inc. ("CTO" or the "Company") (NYSE:CTO) and certain officers. The class action, filed in the United States District Court for the Middle District of Florida, and docketed under
NEW YORK, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ:SLNO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Soleno and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ:RARE). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Ultragenyx and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Necessity Retail REIT, Inc. ("Necessity Retail" or the "Company") (NASDAQ:RTL) who received shares of Global Net Lease, Inc. ("Global Net Lease") in connection with Global Net Lease’s acquisition of Necessity Retail on September
NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ:NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Nutex and certain of its officers and/or
NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of MarineMax, Inc. ("MarineMax" or the "Company") (NYSE:HZO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether MarineMax and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. ("NeoGenomics" or the "Company") (NASDAQ:NEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether NeoGenomics and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / August 23, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. ("Anika" or the "Company") (NASDAQ:ANIK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Anika and certain of its officers and/or